Search clinical trials for: liraglutide

Total 467 results

Milton S. Hershey Medical Center
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Use of a GLP-1R Agonist to Treat Opioid Use Disorder

Opioid-Related Disorders | Opiate Substitution Treatment

United States
Hospital de Clinicas de Porto Alegre

Completed

The Use of Liraglutide in Brain Death

Brain Death

Brazil
University at Buffalo

Completed

Effects of Single Doses of Liraglutide and Dapagliflozin on Ketogenesis in Type 1 Diabetes (1974)

Type 1 Diabetes

United States
Dasman Diabetes Institute

Completed

Obesity Treatment to Improve Diabetes (OTID)

Type 1 Diabetes

Kuwait
Centre Hospitalier Universitaire Dijon

Terminated

Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism (LIRA-NAFLD/LIP)

Type 2 Diabetes

France
Boehringer Ingelheim

Completed

A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes

Diabetes Mellitus, Type 2

Denmark
Novo Nordisk A/S

Completed

Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany
Novo Nordisk A/S

Active, not recruiting

A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America

Obesity

United States
University at Buffalo

Completed

Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes

Type 1 Diabetes Mellitus

United States
University at Buffalo
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Liraglutide in Type 1 Diabetes (1966)

Type 1 Diabetes

United States
Unidad de Cirugia Bariatrica Hospital Civil Dr....

Completed

Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic Surgery

Weight Loss | Obesity, Morbid | Bariatric Surgery Candidate

Mexico
University at Buffalo
Novo Nordisk A/S

Completed

Liraglutide in the Treatment of Type 1 Diabetes Mellitus

Type 1 Diabetes

United States
4Moving Biotech

Completed

Safety, Tolerability and Pharmacokinetics of Intra-articular (IA) Single Ascending Dose of 4P-004 in Patient With Kellgren and Lawrence Grade 2 to 4 Osteoarthritic (OA) Knee (LASARE)

Knee Osteoarthritis

Belgium
Novo Nordisk A/S

Completed

Comparison of Two Liraglutide Formulations in Healthy Volunteers

Healthy | Diabetes

Germany
St Vincent's University Hospital, Ireland
University College Dublin; Health Research Board, Ireland

Completed

Effect of Liraglutide vs CPAP on Cardiometabolic Outcomes in Obstructive Sleep Apnea

Sleep Apnea, Obstructive

Ireland
University of Palermo

Completed

Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients

Diabetes Mellitus, Type 2

Italy
Weill Cornell Medical College in Qatar
University of Hull; Hamad Medical Corporation; Sidra Medical and Research Center

Active, not recruiting

HbA1c Variability in Type II Diabetes

Diabetes Mellitus Type 2

Qatar
Turku University Hospital

Active, not recruiting

Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes (Liragest)

Gestational Diabetes

Finland
Texas Tech University
Novo Nordisk A/S

Completed

To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue Reactivity

Obesity

United States
Xinqiao Hospital of Chongqing
University of Messina; Azienda Ospedaliera Universitaria Policlinico "G. Martino...

Completed

The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

Obesity | Overweight | Polycystic Ovary Syndrome (PCOS)

China
Novo Nordisk A/S

Completed

Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Denmark
Novo Nordisk A/S

Completed

Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 Diabetes

Healthy | Diabetes Mellitus, Type 2 | Diabetes

United Kingdom
AstraZeneca

Completed

Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP) (HARRP)

Type 2 Diabetes Mellitus

Sweden
Population Health Research Institute
Novo Nordisk A/S

Completed

Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira (REMITiDegLira)

Type 2 Diabetes Mellitus

Canada
University of North Carolina, Chapel Hill
Novo Nordisk A/S

Completed

Efficacy of Liraglutide Therapy in Patients With IPAA

Pouchitis | Irritable Pouch Syndrome

United States
Rebecca Ashare
Novo Nordisk A/S

Completed

Daily Liraglutide for Nicotine Dependence (DAL)

Smoking Cessation | Weight, Body

United States
Amgen

Completed

Multiple Ascending Dose Study of AMG 598 in Adults With Obesity

Obesity

United States
Emory University
Novo Nordisk A/S

Completed

IDegLira HIGH Trial

Diabetes Mellitus

United States
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.

Completed

Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity

Obesity

Australia
Beth Israel Deaconess Medical Center

Active, not recruiting

Saxenda: Underlying Mechanisms and Clinical Outcomes

Obesity

United States
Anders Fink-Jensen, MD, DMSci

Completed

Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?

Feasibility | Overweight and Obesity | Metabolic Disturbance | Mental Disorder | Liraglutide

Denmark
National Institute of Diabetes and Digestive and...
Children's National Research Institute

Completed

Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes

Type 2 Diabetes

United States
Brigham and Women's Hospital

Completed

Replication of the LEAD-2 Diabetes Trial in Healthcare Claims Data

Diabetes

United States
Brigham and Women's Hospital

Completed

Replication of the LEADER Diabetes Trial in Healthcare Claims

Diabetes

United States
University of Alberta
Alberta Innovates Health Solutions

Active, not recruiting

Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)

Diabetes Mellitus, Type 1

Canada
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus (PILGRIM)

Diabetes Mellitus Type II

Netherlands
Novo Nordisk A/S

Completed

Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.

Obesity | Overweight

United States, United Kingdom, Canada, Denmark, Finland, Serbia, Poland, Japan, South Africa, Ireland
Mayo Clinic

Completed

Individualized Obesity Pharmacotherapy

Obesity

United States
Novo Nordisk A/S

Enrolling by invitation

Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea

Diabetes Mellitus, Type 2

Korea, Republic of
Novo Nordisk A/S

Completed

Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome

Obesity | Metabolism and Nutrition Disorder

France, United States, Turkey, Italy, Australia, New Zealand, Canada, Netherlands
Novo Nordisk A/S
Eli Lilly and Company; AstraZeneca; United BioSource, LLC

Enrolling by invitation

An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

Diabetes Mellitus, Type 2 | Diabetes | Weight Management | Medullary Thyroid Carcinoma

United States
Shanghai Zhongshan Hospital

Completed

The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients

Overweight | Obese

China
Novo Nordisk A/S

Completed

Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity (STEP 8)

Obesity | Overweight

United States
RISE Study Group
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

RISE Adult Medication Study (RISE Adult)

Type 2 Diabetes | Prediabetes

United States
Groupe Hospitalier Paris Saint Joseph

Active, not recruiting

Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients (LIRADIAL)

Diabetes Mellitus, Type 2 | Hemodialysis | Obese

France
The Cleveland Clinic

Active, not recruiting

EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial (EMPOWER-T2D)

Obesity | Type 2 Diabetes

United States
David Sanchez Garcia
Instituto Mexicano del Seguro Social

Completed

Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Mexico
Eli Lilly and Company

Completed

A Study of LY3537021 in Healthy Participants

Healthy

Singapore
University of Leeds

Completed

Targeting Beta-cell Failure in Lean Patients With Type 2 Diabetes (Lean-DM)

Diabetes Mellitus, Type 2

United Kingdom
Erasme University Hospital

Terminated

Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.

Type 2 Diabetes | Pancreas | Incretinomimetics

Belgium

Search clinical trials for: liraglutide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations